FDA Advisers: How Do Patients Get Virtual Reality Device Risk, Efficacy Info?

Members of the FDA’s Patient Engagement Advisory Committee shared their concerns about augmented reality and virtual reality health care devices at the second day of a PEAC meeting on the topic held Wednesday (July 13), asking how reliable information about the technologies would reach patients and caregivers and what role FDA might play. The advisers discussed what information patients and caregivers should receive about the risks and benefits of new health technologies, as well as what entity should be responsible...